As a subtype of invasive breast cancer (IBC), luminal breast cancer is characterized by the expression of hormone receptors, particularly estrogen receptor (ER) and progesterone receptor (PR), and is typically HER2-negative. Here, ERBB2 is linked to invasive breast carcinoma.